Abstract:Lung cancer is the leading cause of death worldwide with a high metastasis rate. Non-small cell lung cancer accounts for 75-85% of lung cancers. Growing evidences show that some, if not all, tumors derive from a minor subpopulation of cancer cells, also known as cancer stem-like cells (CSCs), either retain or acquire the capacity for self-renewal and drug resistance. By the virtue of altered cell signaling pathways related to cell survival and/or apoptosis, CSCs are able to survive radiation or chemotherapeutic insults. Thus, the targeting of key signaling pathway(s) that is active in CSCs is very attractive therapeutic strategy to treating cancers. However, research has been hampered due to the lack of distinct molecular makers on CSCs. We take advantage of a rare subset of cells that can efflux the DNA binding dye out of the cell. These cells, called side population (SP) cells, are proved to be enriched with CSCs and have stem cell characteristics. We evaluated the existence of SPs in PC-9 cells by staining them with Hoechst 33342. SP cells occupied 0.6-2.4% of the total cells in PC-9 cultures. It was noteworthy that the SP was completely eliminated in the presence of Verapamil. Consistent with our hypothesis that EGFR-TKIs regulate CSC, constitutive activation of EGFR increased the subpopulation almost 4.5-fold to 4.0%, whereas EGFR-TKI almost completely ablated it resulting in only 0.2% or 0.3% of the total cells. To understand the molecular mechanism(s) that EGF promote CSC population, the phosphorylation of EGFR at Tyr1068, AKT at Ser473 and ERK at Thr202/Tyr204 were investigated and they are all positive. More interestingly, EGFR/PI3K/AKT signaling inhibitors including Gefitinib, LY294002, U0126 and Erlotinib, significantly reduced the stem-like cancer cells. These results strongly suggested the importance of EGFR/PI3K/AKT as a potential target of eliminating CSCs. To verify that the effect of EGFR-TKIs on CSC phenotypes is mediated through β-catenin signaling, we used CSC-specific siRNAs to suppress β-catenin expression in PC-9 cells. A significant decrease in cancer stem-like cells was observed following β-catenin suppression. The treatment with Gefitinib dramatically reduced the tumor numbers and size in vivo xenograft model with PC9 cells. Although there were few SP cells (1.3% as detected) in Gefitinib-treated mice in the primary tumors, more discernible numbers of SP cells were detected in Cisplatin-treated (13.6%) or control-treated tumors (8.3%). Most notably, the reduction of SP cells by Gefitinib significantly reduced the migration capability. As a comparison, those primary culture cells derived from Cisplatin-treated tumors had an increased migration rate. Our discoveries raise an intriguing question of the role of β-catenin in acquired resistance of EGFR-TKIs-treated cancer stem cell-like population(s) and its potential as new treatment strategy for NSCLC in the future. Citation Format: Fan Yang, Jiacong You, Yang Li, Jiayu Liao, Qinghua Zhou. Cancer stem cell-like population from non-small cell lung cancer is preferentially suppressed by EGFR-TKIs. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3741. doi:10.1158/1538-7445.AM2013-3741

Combined GSK-3β and MEK inhibitors modulate the stemness and radiotherapy sensitivity of cervical cancer stem cells through the Wnt signaling pathway

The efficacy of PI3Kγ and EGFR inhibitors on the suppression of the characteristics of cancer stem cells

Peer Review #1 of "radiosensitization Effect of Hsa-Mir-138-2-3p on Human Laryngeal Cancer Stem Cells (V0.2)"

Radiosensitization effect of hsa-miR-138-2-3p on human laryngeal cancer stem cells.

Inhibitory Effect and Molecular Mechanism of Mesenchymal Stem Cells on NSCLC Cells

Dual Inhibition of Src and PLK1 Regulate Stemness and Induce Apoptosis Through Notch1-SOX2 Signaling in EGFRvIII Positive Glioma Stem Cells (Gscs).

STEM-20. RADIO-SENSITIZING GLIOBLASTOMA CANCER STEM CELLS BY INHIBITION OF FACT

Gastric Cancer Mesenchymal Stem Cells Regulate PD-L1-CTCF Enhancing Cancer Stem Cell-Like Properties and Tumorigenesis

STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.

Effective elimination of cancer stem cells by a novel drug combination strategy.

MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway

A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma

Elevated expression of Nrf2 mediates multidrug resistance in CD133+ head and neck squamous cell carcinoma stem cells

Promoting Tumor Penetration of Nanoparticles for Cancer Stem Cell Therapy by TGF-β Signaling Pathway Inhibition

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

Abstract 3741: Cancer Stem Cell-Like Population from Non-Small Cell Lung Cancer is Preferentially Suppressed by EGFR-TKIs.

Nuclear EGFR-PKM2 Axis Induces Cancer Stem Cell-Like Characteristics in Irradiation-Resistant Cells.

Mir-140-modified Bone Marrow Mesenchymal Stem Cells Enhance Chemotherapy Sensitization in Cervical Squamous Cell Carcinoma Cells Via Targeting Microtubule Depolymerization Protein 1 (STMN1)

Synergistic Treatment of Cancer Stem Cells by Combinations of Antioncogenes and Doxorubicin

Effect of docetaxel on cancer stem cell-like cells in the mucoepidermoid carcinoma cell line MC3

Aberrantly Elevated Redox Sensing Factor Nrf2 Promotes Cancer Stem Cell Survival Via Enhanced Transcriptional Regulation Of Abcg2 And Bcl-2/Bmi-1 Genes